Results of 60CO-Teletherapy in Oral Cancer

Author:

Volterrani Fabio12,Sigurtà Davide2,Uslenghi Carlo2,Chiesa Fausto3,Molinari Roberto3

Affiliation:

1. Istituto di Scienze Radiologiche, Università, Milano

2. Servizio di Radiologia B, Istituto Nazionale per lo Studio a la Cura dei Tumori, Milano

3. Divisione di Oncologia Clinica C, Istituto Nazionale per lo Studio a la Cura dei Tumori, Milano

Abstract

Our study reports 282 oral cancer cases treated with 60Co-teletherapy (TCT), taken from 736 oral carcinomas treated with radiotherapy on the primary tumor from January 1959 to December 1970. They were mainly locally advanced cases which often had regional node involvement. In fact, during that period, the more advanced cases were submitted to TCT. There were only 9 (3.2 %) patients with T1 lesions, while there were 134 (47.5 %) T2 and 139 (49.3 %) T3, X4 cases; there were respectively 106 (37.6 %) and 44 (15.6 %) N1 or N2 and N3 cases. Almost half of the patients were ≥ 66 years old at onset of the treatment (138/282 cases, or 47.2 %); the women were a small minority (18/282, or 6.4 %). There were 58 (20.6 %) carcinomas of the mucosal surface of the cheeks, 60 cases arising from the retromolar areas, the upper-lower alveolar processes and the hard palate (21.3 %), 72 carcinomas of the mobile portion of the tongue (25.5 %) and 92 arising from the floor of the mouth (32.6 %). All the patients considered in the study were treated with conventional techniques by doses, field dimensions and fractionation. The overall results were objectively disappointing, even though they should be evaluated keepping in mind the nature and the gravity of oral carcinomas submitted to TCT. Actuarial survival at 5 and 10 years from the onset of treatment was respectively 11.6 % and 6.4 %. None of the N1, N3 cases survived beyond the fourth year from onset of the treatment. Long-term survival differs very little in relation to the site of origin in the oral cavity. Nowadays, TCT alone may have only a palliative role in the treatment of oral cancer, reserving it for those cases which, due to their extreme gravity or the various contraindications, do not permit more aggressive treatments. In a combined therapeutic approach the aim of TCT today is to control the minimum disease foci. Its association with surgery appears to be most effective.

Publisher

SAGE Publications

Subject

Cancer Research,Oncology,General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3